Multiple Nucleic Acid Testing Platform

Specialized in HLA Typing technology

Human Leukocyte Antigen (HLA) is a group of closely linked genes that controls mutual recognition between cells and regulates immune response. Therefore, our HLA diagnostic test kits are mainly used for genotyping for high-grade organ transplantation, bone marrow transplants and cord blood transplants to ensure that transplant recipients do not suffer from severe transplant rejection.

TBG (Xiamen), a subsidiary of U-GEN, received the first certificates of HLA high-resolution genotyping diagnostic kits issued by NMPA with the market and have the potential to monopolize the market.

Clinical Applications of HLA Typing

Due to the close association between HLA and specific diseases, HLA genotypes can guide physicians on disease prevention, diagnosis, treatment, and prognosis. Therefore, we continue to expand the clinical application of our HLA genotyping kits to develop individualized medication guidance and to realize our goal of providing precision medical care through self-developed genetic technology.

Transplantation and tissue matching
Disease screening
Cancer treatment evaluation
Viral cancer testing
Drug safety genetic analysis
Evaluating COVID-19 vaccine effectiveness

TBG Biotechnology Xiamen Inc.

  • TBG (Xiamen) was founded in 2014 and mainly engaged in providing professional services and top-grade nucleic acid testing products to hospitals, independent reference labs, blood centers and bone marrow registry labs. During the COVID-19 pandemic in 2020, TBG (Xiamen)  expanded its capability for COVID-19 diagnostic product development and obtained CE certificates for marketing globally.